PDS Biotechnology Corp.

Market Cap: N/A
Industry: Pharmaceuticals & Biotechnology
ISIN: US70465T1079

USD

0.89

0.13 (16.48%)

Dec 04

NAS

Click here to see other stocks

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Zevra Therapeutics, Inc.

XOMA Corp.

Emergent BioSolutions, Inc.

Alimera Sciences, Inc.

Applied Therapeutics, Inc.

Zomedica Corp.

Fusion Pharmaceuticals, Inc.

Atara Biotherapeutics, Inc.

Sagimet Biosciences, Inc.

PDS Biotechnology Corp.

Actinium Pharmaceuticals, Inc.

Why is PDS Biotechnology Corp. ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Is PDS Biotechnology Corp. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

PDS Biotechnology Corp.

-60.26%

-0.91

81.04%

S&P 500

13.22%

0.61

20.17%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

-187.17%

EBIT to Interest (avg)

-16.37

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.94

Sales to Capital Employed (avg)

Tax Ratio

5.43%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

31.10%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

3.45

EV to EBIT

-1.59

EV to EBITDA

-1.59

EV to Capital Employed

43.37

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

-2727.24%

ROE (Latest)

-158.73%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bullish

Bollinger Bands

Bearish

Sideways

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

No Trend

Mildly Bearish

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company

NET PROFIT(HY)

Higher at USD -17.92 MM

RAW MATERIAL COST(Y)

Fallen by 0% (YoY

EPS(Q)

Highest at USD -0.21

-6What is not working for the Company

DEBT-EQUITY RATIO (HY)

Highest at -83.56 %

INTEREST(Q)

Highest at USD 2.14 MM

Here's what is working for PDS Biotechnology Corp.

Net Profit

Higher at USD -17.92 MM

than preceding 12 month period ended Jun 2025

MOJO Watch

In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (USD MM)

EPS

Highest at USD -0.21

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Raw Material Cost

Fallen by 0% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for PDS Biotechnology Corp.

Interest

At USD 2.14 MM has Grown at 130.37%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Interest

Highest at USD 2.14 MM

in the last five periods and Increased by 130.37% (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Debt-Equity Ratio

Highest at -83.56 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio